ASENT

1 stories · following the connections

Business

Axsome Therapeutics Presents Scientific Rationale for the Development of AXS-05 at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics

By Nasdaq OMXMar 12, 2018, 11:00 AM UTC